A trend towards greater reduction in ischaemic events with triple versus dual antithrombotic therapy in older patients was reported in the PIONEER AF-PCI and AUGUSTUS trials, but this did not reach statistical significance [ 20 , 21 , 22 ].
← all excerpts
Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome.
1
—
—